chr20-6041117-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152611.5(LRRN4):c.2128C>A(p.Gln710Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000869 in 1,610,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152611.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRN4 | NM_152611.5 | c.2128C>A | p.Gln710Lys | missense_variant | 5/5 | ENST00000378858.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRN4 | ENST00000378858.5 | c.2128C>A | p.Gln710Lys | missense_variant | 5/5 | 1 | NM_152611.5 | P1 | |
LRRN4 | ENST00000698795.1 | c.*1285C>A | 3_prime_UTR_variant | 5/5 | |||||
LRRN4 | ENST00000698796.1 | n.2419C>A | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000248 AC: 6AN: 241614Hom.: 0 AF XY: 0.0000304 AC XY: 4AN XY: 131746
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1458360Hom.: 0 Cov.: 33 AF XY: 0.00000827 AC XY: 6AN XY: 725378
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.2128C>A (p.Q710K) alteration is located in exon 5 (coding exon 4) of the LRRN4 gene. This alteration results from a C to A substitution at nucleotide position 2128, causing the glutamine (Q) at amino acid position 710 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at